Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline can... Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma. Show more
Significant Demand for Amtagvi™ (Lifileucel) Continues with $58.6M in Total 3Q24 Product Revenue Reaffirming Guidance of $160-$165M for FY24 and $450-$475M for FY25 of Total Product Revenue...
SAN CARLOS, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.64 | 7.41599073001 | 8.63 | 8.715 | 7.98 | 10339122 | 8.2913728 | CS |
| 4 | -1.36 | -12.7939793039 | 10.63 | 12.505 | 7.98 | 8790881 | 9.88280195 | CS |
| 12 | -2.16 | -18.8976377953 | 11.43 | 12.505 | 7.98 | 6313112 | 9.89557009 | CS |
| 26 | -1.02 | -9.91253644315 | 10.29 | 12.505 | 7.11 | 6709332 | 9.38629443 | CS |
| 52 | 3.93 | 73.595505618 | 5.34 | 18.33 | 5.24 | 7406942 | 10.46915249 | CS |
| 156 | -9.56 | -50.7700477961 | 18.83 | 20.6 | 3.21 | 5252569 | 9.34461884 | CS |
| 260 | -12.76 | -57.9210167953 | 22.03 | 54.2081 | 3.21 | 3893568 | 13.15380435 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
